2D lag and signal nonlinearity correction in an amorphous silicon EPID and their impact on pretreatment dosimetric verification
Authors:
- 11 October 2012
- journal article
- Published by Wiley in Medical Physics
- Vol. 39 (11) , 6597-6608
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A study on dosimetric properties of electronic portal imaging device and its use as a quality assurance tool in Volumetric Modulated Arc TherapyReports of Practical Oncology and Radiotherapy, 2011
- Quality assurance of RapidArc in clinical practice using portal dosimetryBritish Journal of Radiology, 2011
- Using an EPID for patient‐specific VMAT quality assuranceMedical Physics, 2011
- Dosimetric properties of an amorphous‐silicon EPID used in continuous acquisition mode for application to dynamic and arc IMRTMedical Physics, 2009
- Portal dose image prediction for in vivo treatment verification completely based on EPID measurementsMedical Physics, 2009
- Assessment of dosimetrical performance in 11 Varian a-Si500 electronic portal imaging devicesPhysics in Medicine & Biology, 2008
- Study protocol of the German "Registry for the Detection of Late Sequelae after Radiotherapy in Childhood and Adolescence" (RiSK)Radiation Oncology, 2008
- Implementation and validation of portal dosimetry with an amorphous silicon EPID in the energy range from 6 to 25 MVPhysics in Medicine & Biology, 2007
- Replacing Pretreatment Verification With In Vivo EPID Dosimetry for Prostate IMRTInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- 64 Dose-response characteristics of an amorphous silicon EPIDRadiotherapy and Oncology, 2005